Shield™ is a leading brand specializing in innovative health solutions, particularly known for its FDA-approved blood test designed for colorectal cancer screening. This test provides healthcare practitioners and patients with a reliable method to detect alterations in cell-free DNA, facilitating early identification of potential cancers. Recommended for individuals aged 45 and older at average risk, the Shield test is lauded for its simplicity—requiring only a small blood sample which can be drawn in-office.

Healthcare professionals endorse Shield™ due to its accurate detection rates for Stages II, III, and IV colorectal cancer, making it a vital tool in preventive healthcare. While the test offers significant advantages, it is important to note that it should not replace traditional methods like colonoscopy for high-risk individuals or those with a history of colorectal issues. Shield™ epitomizes commitment to improving patient outcomes through cutting-edge technology and remains a trusted resource for healthcare providers in cancer screening.